HK1153636A1 - Ophthalmic devices for the controlled release of active agents - Google Patents

Ophthalmic devices for the controlled release of active agents

Info

Publication number
HK1153636A1
HK1153636A1 HK11107888.7A HK11107888A HK1153636A1 HK 1153636 A1 HK1153636 A1 HK 1153636A1 HK 11107888 A HK11107888 A HK 11107888A HK 1153636 A1 HK1153636 A1 HK 1153636A1
Authority
HK
Hong Kong
Prior art keywords
active agents
controlled release
ophthalmic devices
devices
eye
Prior art date
Application number
HK11107888.7A
Other languages
English (en)
Inventor
Zhigang Li
Michael J Trezza
Maureen J Borgia
Aruna Nathan
Bret A Coldren
Original Assignee
Johnson & Johnson Vision Care
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40758669&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1153636(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson Vision Care filed Critical Johnson & Johnson Vision Care
Publication of HK1153636A1 publication Critical patent/HK1153636A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58—Materials at least partially resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • A61F2250/0068—Means for introducing or releasing pharmaceutical products into the body the pharmaceutical product being in a reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A61F9/00772—Apparatus for restoration of tear ducts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Plastic & Reconstructive Surgery (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK11107888.7A 2008-05-07 2011-07-29 Ophthalmic devices for the controlled release of active agents HK1153636A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5108508P 2008-05-07 2008-05-07
PCT/US2009/043139 WO2009137673A1 (en) 2008-05-07 2009-05-07 Ophthalmic devices for the controlled release of active agents

Publications (1)

Publication Number Publication Date
HK1153636A1 true HK1153636A1 (en) 2012-04-05

Family

ID=40758669

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11107888.7A HK1153636A1 (en) 2008-05-07 2011-07-29 Ophthalmic devices for the controlled release of active agents

Country Status (16)

Country Link
US (2) US20090306608A1 (xx)
EP (1) EP2285321B1 (xx)
JP (1) JP2011522575A (xx)
KR (1) KR20110015587A (xx)
CN (1) CN102014817B (xx)
AR (1) AR071691A1 (xx)
AU (1) AU2009244191B2 (xx)
BR (1) BRPI0912252A2 (xx)
CA (1) CA2723361A1 (xx)
ES (1) ES2408163T3 (xx)
HK (1) HK1153636A1 (xx)
IL (1) IL208947A0 (xx)
PL (1) PL2285321T3 (xx)
RU (1) RU2010150095A (xx)
TW (1) TWI542338B (xx)
WO (1) WO2009137673A1 (xx)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
MX2010008998A (es) * 2008-02-18 2010-11-26 Qlt Plug Delivery Inc Implantes lagrimales y metodos relacionados.
US8894602B2 (en) 2010-09-17 2014-11-25 Johnson & Johnson Vision Care, Inc. Punctal plugs with directional release
TW201043211A (en) * 2009-03-31 2010-12-16 Johnson & Johnson Vision Care Inc Punctal plugs
US9421127B2 (en) 2009-03-31 2016-08-23 Johnson & Johnson Vision Care, Inc. Punctal plugs
TWI495459B (zh) * 2009-03-31 2015-08-11 Johnson & Johnson Vision Care 淚管塞（二）
EP4289416A3 (en) * 2009-05-18 2024-01-03 Dose Medical Corporation Drug eluting ocular implant
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
US8808257B2 (en) * 2009-08-31 2014-08-19 Johnson & Johnson Vision Care, Inc. Methods and apparatus for pulsatile release of medicaments from a punctal plug
US9259352B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US9259351B2 (en) 2010-03-29 2016-02-16 Johnson & Johnson Vision Care, Inc. Punctal plugs
US20110251568A1 (en) * 2010-04-08 2011-10-13 Beeley Nathan R F Punctal plugs for controlled release of therapeutic agents
US20110301555A1 (en) * 2010-06-03 2011-12-08 Gonzalez-Zugasti Javier P Porous matrix drug core for lacrimal insert device
US20110311606A1 (en) * 2010-06-18 2011-12-22 Coldren Bret A Punctal plugs with continuous or pulsatile drug release mechanism
US8821457B2 (en) * 2010-09-08 2014-09-02 Johnson & Johnson Vision Care, Inc. Punctal plug containing drug formulation
US20120157938A1 (en) 2010-12-16 2012-06-21 Tokarski Jason M Punctal plug with drug core retention features
US20120215184A1 (en) * 2011-02-18 2012-08-23 Valeant International (Barbados) Srl Cylindrical ocular inserts
US9301874B2 (en) 2011-05-06 2016-04-05 Johnson & Johnson Vision Care, Inc. Punctal plugs for controlled release of therapeutic agents
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
US20130018360A1 (en) * 2011-07-13 2013-01-17 Marissa Dockendorf Method for delivering ophthalmic drugs
US8911227B2 (en) * 2012-01-11 2014-12-16 Johnson & Johnson Vision Care, Inc. Device for injection molding silicone rubber
US9554940B2 (en) 2012-03-26 2017-01-31 Glaukos Corporation System and method for delivering multiple ocular implants
US10507245B2 (en) 2012-07-19 2019-12-17 Luis Felipe Vejarano Restrepo Ophthalmic formulation and method for ameliorating presbyopia
EP2885045A4 (en) * 2012-08-20 2016-07-20 O Ray Pharma Inc METHOD FOR MANUFACTURING DRUG DELIVERY FORMULATIONS
CN105142710A (zh) 2013-01-15 2015-12-09 科罗拉多州立大学董事会,公司实体 泪腺系统给药装置
US10517759B2 (en) 2013-03-15 2019-12-31 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US20140336619A1 (en) * 2013-05-13 2014-11-13 Abbott Cardiovascular Systems Inc. Ophthalmic shunt and method
WO2015160492A1 (en) 2014-04-16 2015-10-22 Hollister Incorporated Molded catheter tip
EP3677229A1 (en) 2014-05-29 2020-07-08 Glaukos Corporation Implants with controlled drug delivery features
KR20180034541A (ko) * 2015-07-22 2018-04-04 인셉트, 엘엘씨 코팅된 눈물점마개
US11925578B2 (en) 2015-09-02 2024-03-12 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) * 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US11857461B2 (en) 2015-11-23 2024-01-02 The Regents Of The University Of Colorado, A Body Corporate Lacrimal system for drug delivery
JP7003110B2 (ja) 2016-04-20 2022-01-20 ドーズ メディカル コーポレーション 生体吸収性眼球薬物送達デバイス
AU2017268379A1 (en) 2016-05-20 2018-12-06 The Regents Of The University Of Colorado, A Body Corporate Lacrimal drug delivery device
SG11202000497VA (en) 2017-07-25 2020-02-27 PK Med SAS Process for preparing a drug delivery composition

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4803076A (en) * 1986-09-04 1989-02-07 Pfizer Inc. Controlled release device for an active substance
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
DE4431653C2 (de) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts Manteltablette zur kontrollierten Freisetzung von Wirkstoffen, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US6020445A (en) 1997-10-09 2000-02-01 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6822016B2 (en) 2001-09-10 2004-11-23 Johnson & Johnson Vision Care, Inc. Biomedical devices containing internal wetting agents
US5962548A (en) 1998-03-02 1999-10-05 Johnson & Johnson Vision Products, Inc. Silicone hydrogel polymers
US6367929B1 (en) 1998-03-02 2002-04-09 Johnson & Johnson Vision Care, Inc. Hydrogel with internal wetting agent
US6196993B1 (en) * 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
US6099852A (en) 1998-09-23 2000-08-08 Johnson & Johnson Vision Products, Inc. Wettable silicone-based lenses
US6565535B2 (en) * 2000-06-16 2003-05-20 Nardo Zaias Medical infusion and aspiration system
GB0117618D0 (en) * 2001-07-19 2001-09-12 Phoqus Ltd Pharmaceutical dosage form
US6921390B2 (en) * 2001-07-23 2005-07-26 Boston Scientific Scimed, Inc. Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
US20080038317A1 (en) * 2004-09-10 2008-02-14 Chin-Ming Chang Therapeutic Lacrimal Canalicular Inserts And Related Methods
CN2897206Y (zh) * 2006-01-12 2007-05-09 温州医学院眼视光研究院 便持式巩膜塞
US20080045911A1 (en) * 2006-06-21 2008-02-21 Borgia Maureen J Punctal plugs for the delivery of active agents
SG138567A1 (en) * 2006-06-21 2008-01-28 Johnson & Johnson Vision Care Punctal plugs for the delivery of active agents
CN101505695A (zh) * 2006-06-21 2009-08-12 庄臣及庄臣视力保护公司 用于递送活性试剂的泪点塞

Also Published As

Publication number Publication date
AU2009244191B2 (en) 2015-05-14
AR071691A1 (es) 2010-07-07
EP2285321B1 (en) 2013-04-03
PL2285321T3 (pl) 2013-09-30
JP2011522575A (ja) 2011-08-04
AU2009244191A1 (en) 2009-11-12
TW201006452A (en) 2010-02-16
RU2010150095A (ru) 2012-06-20
CN102014817B (zh) 2014-06-04
WO2009137673A1 (en) 2009-11-12
US20110022007A1 (en) 2011-01-27
CN102014817A (zh) 2011-04-13
US8377042B2 (en) 2013-02-19
KR20110015587A (ko) 2011-02-16
EP2285321A1 (en) 2011-02-23
ES2408163T3 (es) 2013-06-18
IL208947A0 (en) 2011-01-31
US20090306608A1 (en) 2009-12-10
CA2723361A1 (en) 2009-11-12
BRPI0912252A2 (pt) 2017-06-13
TWI542338B (zh) 2016-07-21

Similar Documents

Publication Publication Date Title
HK1153636A1 (en) Ophthalmic devices for the controlled release of active agents
HK1258967A1 (zh) 用於遞送疏水性舒適劑的眼用設備
MX2010002504A (es) Articulos absorbentes desechables para llevar puestos con sistemas secundarios de fijacion.
EP2019646A4 (en) METHOD, DEVICE AND SYSTEM FOR THE RELEASE OF A THERAPEUTIC ACTIVE IN THE EYE
MX349941B (es) Aplicadores antisepticos y tecnicas de envasado.
WO2010068281A3 (en) Contact lens drug delivery device
MX2009004365A (es) Dispositivos oculares y metodos para la fabricacion y uso de los mismos.
SG10201804552WA (en) Nanoparticle compositions, formulations thereof, and uses therefor
PH12015500115A1 (en) Glucagon analogues
MX357598B (es) Dispositivos intravaginales para administración de fármaco.
MX2007010752A (es) Usos oftalmicos de moduladores de receptor s1p.
EP4275752A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
WO2009031070A3 (en) Disposable wearable absorbent articles with anchoring subsystems
WO2009031069A3 (en) Disposable wearable absorbent articles with anchoring subsystems
MX340636B (es) Dispositivo oftalmico que tiene capacidad de liberacion de agentes terapeuticos y metodos para formar el mismo.
NZ608202A (en) Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof
IL211694A0 (en) Use of-anti-connexin agents for modulating the therapeutic effect of psychotropic drugs
EA201071166A1 (ru) Контролируемое высвобождение активных агентов из олеосом
MX2015004900A (es) Paquetes de liberacion pasiva de sustancias quimicas del fondo de la perforacion.
EP2515917A4 (en) COMPOSITIONS AND METHODS FOR EYE-UP
MX2014006136A (es) Uso de aril- y hetarilcarboxamidas como endoparasiticidas.
MX356813B (es) Derivados de hidantoina utiles como inhibidores de kv3.
IN266731B (xx)
MY143269A (en) Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
MY174903A (en) Ophthalmic devices for delivery of beneficial agents